Understanding and preventing contrast-induced acute kidney injury
- PMID: 28138128
- DOI: 10.1038/nrneph.2016.196
Understanding and preventing contrast-induced acute kidney injury
Abstract
Contrast-induced acute kidney injury (CIAKI) occurs in up to 30% of patients who receive iodinated contrast media and is generally considered to be the third most common cause of hospital-acquired AKI. Accurate assessment of the incidence of CIAKI is obscured, however, by the use of various definitions for diagnosis, the different populations studied and the prophylactic measures put in place. A deeper understanding of the mechanisms that underlie CIAKI is required to enable reliable risk assessment for individual patients, as their medical histories will determine the specific pathways by which contrast media administration might lead to kidney damage. Here, we highlight common triggers that prompt the development of CIAKI and the subsequent mechanisms that ultimately cause kidney damage. We also discuss effective protective measures, such as rapidly acting oral hydration schemes and loop diuretics, in the context of CIAKI pathophysiology. Understanding of how CIAKI arises in different patient groups could enable a marked reduction in incidence and improved outcomes. The ultimate goal is to shape CIAKI prevention strategies for individual patients.
Similar articles
-
Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI).Curr Pharm Des. 2019;25(44):4642-4647. doi: 10.2174/1381612825666191210152944. Curr Pharm Des. 2019. PMID: 31820694 Review.
-
Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials.Ren Fail. 2015 May;37(4):664-71. doi: 10.3109/0886022X.2015.1010939. Epub 2015 Feb 23. Ren Fail. 2015. PMID: 25703707 Review.
-
Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.Catheter Cardiovasc Interv. 2020 Apr 1;95(5):895-903. doi: 10.1002/ccd.28386. Epub 2019 Jul 8. Catheter Cardiovasc Interv. 2020. PMID: 31282129
-
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.Circ Cardiovasc Interv. 2017 May;10(5):e004383. doi: 10.1161/CIRCINTERVENTIONS.116.004383. Circ Cardiovasc Interv. 2017. PMID: 28487354
-
Contrast-induced kidney injury: mechanisms, risk factors, and prevention.Eur Heart J. 2012 Aug;33(16):2007-15. doi: 10.1093/eurheartj/ehr494. Epub 2012 Jan 19. Eur Heart J. 2012. PMID: 22267241 Review.
Cited by
-
Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases.Curr Res Pharmacol Drug Discov. 2024 Oct 26;7:100206. doi: 10.1016/j.crphar.2024.100206. eCollection 2024. Curr Res Pharmacol Drug Discov. 2024. PMID: 39524210 Free PMC article. Review.
-
Development of machine learning prediction model for AKI after craniotomy and evacuation of hematoma in craniocerebral trauma.Medicine (Baltimore). 2024 Nov 1;103(44):e39735. doi: 10.1097/MD.0000000000039735. Medicine (Baltimore). 2024. PMID: 39496042 Free PMC article.
-
Image Quality and Lesion Detectability of Low-Concentration Iodine Contrast and Low Radiation Hepatic Multiphase CT Using a Deep-Learning-Based Contrast-Boosting Model in Chronic Liver Disease Patients.Diagnostics (Basel). 2024 Oct 17;14(20):2308. doi: 10.3390/diagnostics14202308. Diagnostics (Basel). 2024. PMID: 39451631 Free PMC article.
-
Short term sodium glucose transport protein 2 inhibitors are associated with post contrast acute kidney injury in patients with diabetes.Sci Rep. 2024 Oct 2;14(1):22937. doi: 10.1038/s41598-024-74233-7. Sci Rep. 2024. PMID: 39358407 Free PMC article.
-
The High-Sensitivity C-Reactive Protein to High-Density Lipoprotein Cholesterol Ratio and the Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.Rev Cardiovasc Med. 2024 Sep 23;25(9):338. doi: 10.31083/j.rcm2509338. eCollection 2024 Sep. Rev Cardiovasc Med. 2024. PMID: 39355575 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
